ArticleJournal of medicinal chemistry2023

Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective.

Przemyslaw Grygier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.